News

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
The past few months have been rather gloomy in the health research space in Kenya. It all started with withdrawal of the USAID funding, bringing to a halt some ongoing research programmes in the ...
An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...
The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.
A LARGE-scale genomic surveillance study in France has found that resistance to nirsevimab, a monoclonal antibody used to prevent respiratory syncytial virus (RSV) in infants, remains rare despite ...
HMPV is similar to a virus that is better known in the United States — respiratory syncytial virus, or R.S.V. It causes symptoms much like those associated with flu and Covid, including cough ...
Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged 75 years and above. Recent advancements in vaccine trials for older ...
Stephanie Soucheray, MA Topics Respiratory Syncytial Virus (RSV) FotoDuets / iStock A new study in The Lancet Infectious Diseases describes the genotypic and phenotypic characteristics of respiratory ...
1. Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and symptoms of hospitalized young children with RSV infection. 2. The ...
PMID: 15858184. 5 Papi A. et al, “ Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults”, in New England Journal of Medicine, 2023;388:595-608 DOI: 10.1056/NEJMoa2209604.
Respiratory syncytial virus (RSV) infections are estimated to cause 3.6 million hospitalizations annually and 97,200 to 124,900 deaths among children 5 years of age or younger worldwide, primarily ...
Respiratory syncytial virus (RSV) is the second most common pathogen causing infant mortality. Additionally, RSV is a major cause of morbidity and mortality in older adults (age ≥60 years) similar to ...